Alliance Pharma plc (LON:APH - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 38.35 ($0.50) and traded as high as GBX 46.65 ($0.60). Alliance Pharma shares last traded at GBX 44.45 ($0.58), with a volume of 1,309,992 shares.
Alliance Pharma Price Performance
The stock has a market cap of £243.26 million, a price-to-earnings ratio of -745.83, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67. The stock's 50 day moving average price is GBX 42.16 and its two-hundred day moving average price is GBX 38.35. The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46.
Alliance Pharma Company Profile
(
Get Free Report)
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Recommended Stories
Before you consider Alliance Pharma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alliance Pharma wasn't on the list.
While Alliance Pharma currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
